XML 144 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Derivative Liabilities (Tables)
6 Months Ended 12 Months Ended
Jun. 30, 2025
Dec. 31, 2024
Derivative Liabilities [Line Items]    
Schedule of Common Stock Purchase Derivative Liability Warrants

A continuity of the Company’s common stock purchase derivative liability warrants is as follows:

 

    Derivative
liabilities
 
Outstanding, December 31, 2023   $ 369,158  
Change in fair value of derivative liabilities     (369,158 )
Outstanding, December 31, 2024   $
-
 
Change in fair value of derivative liabilities    
-
 
Outstanding, June 30, 2025   $
-
 

A continuity of the Company’s common stock purchase derivative liability warrants is as follows:

 

    Derivative liabilities  
Outstanding, December 31, 2022   $ 68,455  
Addition of new derivatives during IPO     229,437  
Change in fair value of derivative liabilities     71,266  
Outstanding, December 31, 2023   $ 369,158  
Change in fair value of derivative liabilities     (369,158 )
Outstanding, December 31, 2024   $ -  
Warrant [Member]    
Derivative Liabilities [Line Items]    
Schedule of Warrants Outstanding

As of June 30, 2025, the following warrants were outstanding:

 

Outstanding     Expiry date   Weighted average
exercise price ($)
 
  167     April 27, 2027     2,817  
  54     November 21, 2028     5,600  
  221           3,497  

As of December 31, 2024, the following warrants were outstanding:

 

Outstanding     Expiry date1     Weighted average exercise price ($)  
  167       April 27, 2027       2,817  
  54       November 21, 2028       5,600  
  221               3,497  
1 On April 28, 2023, the Company amended the warrant agreements for the 167 derivative liability warrants outstanding. The amendment removed the clause to automatically convert warrants to shares on IPO date and all warrants were given an expiry date of April 27, 2027. This led to an increase in the expected life input in the Black-Scholes model as of December 31, 2023 compared to December 31, 2022, when the Company used the expected IPO date to calculate the expected life of the warrants.
Schedule of Black-Scholes Option Pricing Model  

The following assumptions were used in the Black-Scholes option pricing model:

 

    December 31,
2024
    December 31,
2023
    November 21,
2023
    December 31,
2022
    July 15,
2022
 
Risk-free interest rate     4.25% - 4.27%       3.84 - 4.01%       4.41%     4.73%     3.12%
Expected life 1     2.32 – 3.90 years       3.32 – 4.90 years       5 years       0.75 years       0.6 years  
Expected dividend rate     0.00%     0.00%     0.00%     0.00%     0.00%
Expected volatility     100%     100%     100%     100%     100.00%
1 On April 28, 2023, the Company amended the warrant agreements for the 167 derivative liability warrants outstanding. The amendment removed the clause to automatically convert warrants to shares on IPO date and all warrants were given an expiry date of April 27, 2027. This led to an increase in the expected life input in the Black-Scholes model as of December 31, 2023 compared to December 31, 2022, when the Company used the expected IPO date to calculate the expected life of the warrants.